Recombinant Klebsiella pneumoniae subsp. pneumoniae NADH-quinone oxidoreductase subunit K (nuoK) is a bioengineered protein derived from the NADH dehydrogenase I (NDH-1) complex, a critical component of the bacterial respiratory chain. This subunit plays a role in electron transport and sodium (Na⁺) translocation, contributing to cellular energy metabolism. The recombinant version is expressed in E. coli with an N-terminal His-tag for purification and structural studies .
NuoK is part of NDH-1, a sodium-translocating NADH:quinone oxidoreductase (Na⁺-NQR) that couples NADH oxidation to Na⁺ extrusion. This mechanism is distinct from proton-pumping NDH-1 complexes in other bacteria . Key findings include:
Na⁺ Transport: NDH-1 in K. pneumoniae actively pumps Na⁺ across the membrane, contributing to the proton motive force and cellular pH regulation .
Metabolic Impact: Disruption of NDH-1 increases intracellular NADH levels, enhancing biosynthesis of redox-sensitive metabolites like 2,3-butanediol .
Studies highlight the potential of nuoK knockout mutants for industrial bioproduction:
While nuoK itself is not directly implicated in virulence, K. pneumoniae employs NDH-1 alongside other NQOs (e.g., NDH-2, NQR) to adapt to environmental stress. Notably:
Antibiotic Resistance: NDH-1-deficient strains show reduced fitness, suggesting metabolic vulnerabilities exploitable in therapy .
Genomic Diversity: K. pneumoniae subsp. pneumoniae harbors multiple clonal groups (e.g., CG307, CG15) associated with multidrug resistance .
Recombinant nuoK requires specialized handling:
KEGG: kpn:KPN_02669
STRING: 272620.KPN_02669
NADH-quinone oxidoreductase subunit K (nuoK) is a membrane protein component of NADH dehydrogenase I (NDH-1) in Klebsiella pneumoniae subsp. pneumoniae. It functions as part of the respiratory chain complex I, which is responsible for electron transport during cellular respiration. In the Uniprot database, this protein is identified by accession number A6TBW5. The protein consists of 100 amino acids with the sequence "MIPLTHGLILAAILVLGLTGLVIRRNLLFMLISLEIMINÁAALAFVVAGSYWGQADGQIMYILAISLAAAEASIGLALLLQLHRRRQNLNIDSVSELRG." Its systematic name is EC 1.6.99.5, which classifies it as an oxidoreductase acting on NADH with various acceptors .
While the search results don't provide direct comparison data for nuoK specifically, we can infer conservation patterns based on similar research methodologies. Using bioinformatic approaches similar to those used for other bacterial proteins, researchers can determine the conservation of nuoK across species. For instance, when studying other proteins within the Paramyxovirus family, researchers performed sequence alignment comparison using the NCBI blast tool and MEGA X with the clustalW algorithm . This approach revealed conservation levels ranging from 97.8% to 100% identity for some proteins. For nuoK research, a similar methodological approach would involve:
Collecting nuoK sequences from various bacterial species
Using multiple sequence alignment tools (MEGA X, Clustal Omega)
Performing phylogenetic analysis to determine evolutionary relationships
Identifying conserved domains and functional motifs
For the expression of recombinant nuoK, researchers typically employ bacterial expression systems, particularly E. coli, as evidenced by similar recombinant protein production methods. The methodology involves:
Cloning the ORF of the nuoK gene into an expression vector such as pET-SUMO
Transforming the recombinant plasmid into competent E. coli cells
Growing bacterial cultures in LB medium supplemented with appropriate antibiotics
Inducing protein expression with IPTG when the culture reaches 0.5-0.6 OD
The pET-SUMO expression system is particularly advantageous for membrane proteins like nuoK because the SUMO tag can enhance solubility and facilitate purification. For optimal expression, researchers should consider using E. coli strains designed for membrane protein expression, such as C41(DE3) or C43(DE3).
Based on these findings, researchers investigating nuoK as a potential vaccine candidate should consider:
Evaluating nuoK conservation across K. pneumoniae strains to assess breadth of coverage
Testing recombinant nuoK's ability to elicit antigen-specific antibodies (IgG, IgG1, IgG2a)
Measuring T-cell responses, particularly IFN-γ-, IL4-, and IL17A-mediated immune responses
Developing challenge models to evaluate protective efficacy
Considering nuoK as part of a multivalent approach rather than a standalone antigen
The protective immune response evaluation should follow protocols similar to those used for KOMPs, where mice were vaccinated and then challenged with K. pneumoniae to assess survival rates and immune response markers .
Membrane proteins such as nuoK present several experimental challenges:
| Challenge | Description | Potential Solution |
|---|---|---|
| Low expression yields | Membrane proteins often express poorly in standard systems | Use specialized strains (C41/C43); optimize codon usage; lower induction temperature |
| Protein misfolding | Improper folding in heterologous systems | Include chaperones; use mild detergents; consider membrane-mimetic systems |
| Purification difficulties | Extraction from membranes without denaturation | Develop optimized detergent screening protocols; use native purification methods |
| Structural analysis | Challenging to crystallize for structural studies | Consider cryo-EM; use NMR for smaller fragments; computational modeling |
| Functional assays | Difficult to assess activity outside native environment | Develop reconstitution systems; liposome incorporation; whole-cell assays |
Researchers must carefully optimize each step of expression and purification to maintain the native structure and function of nuoK.
K. pneumoniae can develop into "superbugs" that are highly resistant to antibiotics . While the search results don't directly link nuoK to antibiotic resistance, as part of the respiratory chain, nuoK could potentially contribute to:
Energy metabolism adaptations that support survival under antibiotic stress
Membrane potential maintenance that affects the efficacy of certain antibiotics
Electron transport chain modifications that alter bacterial physiology during infection
Research approaches to investigate this relationship should include:
Generating nuoK knockout strains and assessing changes in antibiotic susceptibility
Performing transcriptomic and proteomic analyses to identify regulatory networks involving nuoK
Using site-directed mutagenesis to identify critical residues that affect both enzyme function and antibiotic resistance
Assessing nuoK expression levels in clinical isolates with varying antibiotic resistance profiles
Verifying both the structure and function of recombinant nuoK requires multiple complementary approaches:
Structural Verification:
Computational Modeling: Similar to approaches used for other proteins, molecular modeling can be performed via the SWISS-MODEL server using appropriate templates. The predicted structures can be visualized and analyzed using programs like PyMOL .
Circular Dichroism (CD): To assess secondary structure content and proper folding
Limited Proteolysis: To verify domain organization and structural integrity
Mass Spectrometry: For accurate mass determination and potential post-translational modifications
Functional Verification:
NADH Oxidation Assays: Measuring the rate of NADH oxidation in the presence of suitable electron acceptors
Reconstitution Studies: Incorporating purified nuoK into liposomes or nanodiscs to measure activity
Membrane Potential Measurements: Using fluorescent dyes to assess the protein's contribution to membrane potential
Complementation Studies: Testing whether recombinant nuoK can restore function in nuoK-deficient bacterial strains
Understanding protein-protein interactions is crucial for elucidating nuoK's role within the respiratory complex. Recommended methodological approaches include:
Co-immunoprecipitation (Co-IP): Using antibodies against nuoK or interacting partners to pull down protein complexes
Bacterial Two-Hybrid System: Adapted for membrane proteins to detect direct interactions
Crosslinking Mass Spectrometry: Identifying interaction interfaces through chemical crosslinking followed by MS analysis
Förster Resonance Energy Transfer (FRET): For studying interactions in living cells
Surface Plasmon Resonance (SPR): Measuring binding kinetics between nuoK and potential partners
The experimental design should consider the hydrophobic nature of nuoK and use appropriate detergents or membrane mimetics to maintain protein stability throughout the analyses.
K. pneumoniae is known to cause both hospital-acquired and community-acquired infections . While nuoK's specific role in pathogenesis isn't directly addressed in the search results, respiratory chain components often contribute to bacterial virulence. Researchers should consider:
Evaluating nuoK expression during different stages of infection
Creating nuoK mutants and testing them in infection models
Assessing the protein's contribution to survival under host-imposed stresses
Investigating whether nuoK affects the expression of known virulence factors
Research should focus on how energy metabolism, specifically through nuoK function, supports bacterial adaptation to host environments and contributes to virulence.
Multi-omics Integration: Combining transcriptomics, proteomics, and metabolomics to understand how nuoK responds to environmental changes
Network Analysis: Identifying regulatory networks that control nuoK expression and activity
Flux Balance Analysis: Modeling how changes in nuoK activity affect metabolic fluxes
Comparative Genomics: Analyzing nuoK conservation and evolution across bacterial species
These approaches would help place nuoK within the broader context of bacterial metabolism and pathogenesis, potentially identifying novel therapeutic targets.